Hypersensitivity to the active substances; Concomitant use with monoamine oxidase inhibitors (MAOIs) (see Interactions); Concomitant use with potent inhibitors of CYP450 isoenzymes; Porphyria.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education